Zhen Kou
Ueruemqi, 830001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Analysis of the Gene Mutation Distribution and Its Relationship with Prognosis in Patients with Primary Gastrointestinal Diffuse Large B-Cell Lymphoma by Next Generation Sequencing
Journal: Zhongguo shi yan xue ye xue za zhi
Published: August 03, 2026
The Prognostic Predictive Value of TP53 mutation Variant Allele Frequency in Diffuse Large B-Cell Lymphoma
Journal: Zhongguo shi yan xue ye xue za zhi
Published: January 01, 2025
Establishment and Evaluation of Prognostic Prediction Model for Diffuse Large B-Cell Lymphoma Patients Based on International Prognostic Index and FAT4, TP53 Mutation.
Journal: Acta haematologica
Published: October 22, 2024
Association between low incidence of TP53 mutations and reduced early relapse rates in Uygur DLBCL.
Journal: Annals of hematology
Published: March 14, 2024
Identification of FAT4 as a positive prognostic biomarker in DLBCL by comprehensive genomic analysis.
Journal: Clinical and experimental medicine
Published: October 21, 2022
Distribution and prognostic value of LymphGen genotyping in patients with diffuse large B-cell lymphoma
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: June 09, 2022
CARD11 is a novel target of miR-181b that is upregulated in chronic lymphocytic leukemia.
Journal: Biomarkers in medicine
Published: May 27, 2021
Expression Level and Target Gene Prediction of miR-181b in Patients with Chronic Lymphocytic Leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 20, 2020
miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
Journal: Molecular and cellular probes
Published: March 13, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026